# Qbic Fund

Qbic Fund is a Private Equity based in Gent, Belgium.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Gent, Belgium
- **Region:** Europe
- **Address:** Qbic Soenenspark 56, 9051 St-Denijs-Westrem, Belgium
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** www.qbic.be
- **LinkedIn:** https://www.linkedin.com/company/qbic

## Regulatory record

- **Reports private funds:** No

## About

Qbic Fund is a venture capital fund investing in spin-off companies from the universities of Ghent, Brussels, and Antwerp. It focuses on life sciences, new materials, cleantech, and ICT start-ups. Founded in 2012 in Sint-Denijs-Westrem, Belgium, the fund has made 74 investments, including a Series A investment in Firecell on February 18, 2026.

## Sectors

- Enterprise Software
- AI/ML
- Digital Health
- Biotech
- Robotics & Automation
- AgriTech & FoodTech
- Energy Transition & Renewables
- Industrial Tech
- Mobility & Transportation
- Media & Entertainment

## People

- Sofie Baeten — Managing Partner
- Steven Leuridan — Managing Partner
- Cédric Van Nevel — Managing Partner
- Sara Vandenwijngaert — Investment Manager
- Danny Gonnissen — CFO
- Vincent Lenders — Investment Manager
- Tom Smets — Investment Manager
- Martin De Prycker — Managing Partner, Qbic I

## Questions

### How does Qbic Fund source its deal flow?

Qbic's pipeline originates almost exclusively from a consortium of Flemish knowledge partners — universities, research institutes, and teaching hospitals. The fund backs spin-offs and startups with formal R&D collaborations tied to these institutions. This creates a structured, not market-facing, origination model that gives Qbic early access to academic breakthroughs before they reach broader venture markets.

### What investment stages does Qbic Fund target?

Qbic invests from pre-seed through growth stages. The firm is often the first institutional investor in a spin-off, using seed and early-stage equity to bridge the gap between laboratory discovery and commercial viability. Follow-on participation in later rounds is common for portfolio companies that achieve technical and clinical milestones.

### Which sectors does Qbic Fund focus on?

The portfolio concentrates on hard-science and deep-tech verticals: digital health, biotechnology, AI and enterprise software, robotics, advanced materials, agritech, and photonics. Representative companies include MRM Health (microbiome therapeutics), eyeo (photonics for imaging), and AILOS Robotics (next-generation actuation).

### Who runs investment decisions at Qbic Fund?

The management team is led by Managing Partners Sofie Baeten, Steven Leuridan, and Cédric Van Nevel. Baeten and Leuridan hold PhDs in materials science and biomechanical engineering, respectively, while Van Nevel brings corporate venturing experience from Bekaert. Investment decisions draw on this combined technical and financial expertise, with PhD-level managers covering life sciences and engineering sectors.

### Is Qbic Fund structured as a single entity or a series of funds?

Qbic operates through sequential fund vehicles — Qbic I, II, and III — each with a distinct vintage and investor base. The third fund was actively deploying capital as of 2024, including a pre-seed investment in Innocens. This multi-fund structure allows the firm to raise discrete pools of capital while maintaining continuity in its university-linked investment strategy.

## Related profiles

- [QBE Europe](https://altss.com/profile/qbe-europe)
- [QBIT Capital](https://altss.com/profile/qbit-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/qbic-fund

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology